An almost sure uptrend starts. Well high probability trade evident on the charts for DXCM.
Even high probability does not mean much sometimes due to changes in market conditions and external factors. so trade with Trailing Stop loss.
1.40USD
541.50 MUSD
3.62 BUSD
377.37 M
About DexCom, Inc.
Sector
Industry
CEO
Kevin Ronald Sayer
Website
Headquarters
San Diego
Employees (FY)
9.6 K
Founded
1999
ISIN
US2521311074
FIGI
BBG000QTF8K1
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DXCM is 134.30 USD — it has increased by 0.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DexCom, Inc. stocks are traded under the ticker DXCM.
DexCom, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
DXCM stock is 1.80% volatile and has beta coefficient of 1.05. Check out the list of the most volatile stocks — is DexCom, Inc. there?
One year price forecast for DexCom, Inc. has a max estimate of 170.00 USD and a min estimate of 122.00 USD.
DXCM earnings for the last quarter are 0.50 USD whereas the estimation was 0.34 USD which accounts for 46.77% surprise. Estimated earnings for the next quarter are 0.43 USD. See more details about DexCom, Inc. earnings.
DexCom, Inc. revenue for the last quarter amounts to 975.00 M USD despite the estimated figure of 939.64 M USD. In the next quarter revenue is expected to reach 1.02 B USD.
Yes, you can track DexCom, Inc. financials in yearly and quarterly reports right on TradingView.
DXCM stock has fallen by 4.14% compared to the previous week, the month change is a 0.35% rise, over the last year DexCom, Inc. has showed a 13.08% increase.
DXCM net income for the last quarter is 256.30 M USD, while the quarter before that showed 120.70 M USD of net income which accounts for 112.34% change. Track more DexCom, Inc. financial stats to get the full picture.
Today DexCom, Inc. has the market capitalization of 51.61 B, it has increased by 2.41% over the last week.
No, DXCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DXCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DexCom, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 9.60 K employees. See our rating of the largest employees — is DexCom, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DexCom, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DexCom, Inc. stock shows the buy signal. See more of DexCom, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DexCom, Inc. future price: according to them, DXCM price has a max estimate of 170.00 USD and a min estimate of 122.00 USD. Read a more detailed DexCom, Inc. forecast: see what analysts think of DexCom, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DexCom, Inc. EBITDA is 783.70 M USD, and current EBITDA margin is 21.64%. See more stats in DexCom, Inc. financial statements.